Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:duloxetine
|
| gptkbp:ATCCode |
gptkb:N06AX21
|
| gptkbp:contains |
gptkb:duloxetine_hydrochloride
|
| gptkbp:contraindication |
concomitant use with MAOIs
uncontrolled narrow-angle glaucoma |
| gptkbp:form |
20 mg
40 mg 30 mg delayed-release capsule 60 mg |
| https://www.w3.org/2000/01/rdf-schema#label |
Drizalma Sprinkle
|
| gptkbp:indication |
gptkb:generalized_anxiety_disorder
gptkb:major_depressive_disorder fibromyalgia chronic musculoskeletal pain diabetic peripheral neuropathic pain |
| gptkbp:manufacturer |
gptkb:Sun_Pharmaceutical_Industries
|
| gptkbp:mechanismOfAction |
norepinephrine reuptake inhibitor
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation dizziness dry mouth somnolence decreased appetite increased sweating |
| gptkbp:bfsParent |
gptkb:DB01216
gptkb:DB01235 gptkb:DB01213 |
| gptkbp:bfsLayer |
7
|